DARKPOOL0.1.0
AFT-MKT Sign in
LBRX
LB Pharmaceuticals Inc
NGM Equity
44.71
-0.23 (-0.51%)
52w low 14.40 50.16 high
84.8% of range

Financial Analysis

Quarterly
(USD) Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26 Trend
Operating Cash Flow ---5.60M-3.37M-18.10M-23.29M-37.63M
Depreciation & Amort --76.00K81.00K85.00K82.00K97.00K
Capital Expenditure -21.00K-----40.00K-32.00K-363.00K
Free Cash Flow ---5.59M-3.37M-18.14M-23.32M-37.99M
Investing Cash Flow --9.00K-44.84M-40.00K-32.00K89.00K
Financing Cash Flow --0.00303.73M-1.17M93.83M-19.00K
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--